Pasquale Esposito

Plain English
This study looked at how a medication called dapagliflozin affects oxygen levels in the kidneys of patients with chronic kidney disease (CKD). The researchers found that after 12 weeks, dapagliflozin significantly improved kidney oxygenation in the medullary area, with a specific measurement showing a P value of 0.015, meaning the results were statistically significant. This is important because better kidney oxygenation may help protect against further kidney damage, especially in nondiabetic patients. Who this helps: Patients with chronic kidney disease, particularly those who are nondiabetic.

Plain English
Researchers studied how a medication called dapagliflozin affects blood vessel stiffness and blood pressure in patients with chronic kidney disease (CKD), both with and without diabetes. They found that after six months, patients taking dapagliflozin had a significant reduction in the stiffness of their blood vessels (a measure known as AASI), scoring 0.50 compared to 0.62 in the placebo group. This finding is important because lower arterial stiffness can lead to better cardiovascular health, even without changes in blood pressure. Who this helps: This benefits patients with chronic kidney disease, especially those with diabetes.

Plain English
This study looked at how effective voclosporin, a medication, is for treating patients with lupus nephritis (LN), a type of kidney disease caused by lupus. Researchers followed 42 patients and found that 31.5% showed improvement in kidney function after 6 weeks, which increased to 91.6% after 48 weeks. The treatment also significantly reduced protein levels in urine—an important indicator of kidney health—indicating that voclosporin could be a helpful option for managing this condition. Who this helps: Patients with lupus nephritis.

Plain English
This study looked at the occurrence and effects of acute kidney injury (AKI) in cancer patients who were hospitalized between 2016 and 2019. Out of 56,390 patients, 6,723 (11.9%) had cancer, and the incidence of AKI was 30.1% in these patients, which is notably higher than the 19.6% seen in non-cancer patients. Notably, stage 3 AKI increased the risk of death by 37%, highlighting the need for better prevention and early detection strategies to help these patients. Who this helps: This research benefits hospitalized cancer patients and their healthcare providers.

Plain English
This study looked at how a medication called dapagliflozin affects patients with Fabry disease (FD) who also have chronic kidney disease (CKD) and high levels of protein in their urine. After one year of taking dapagliflozin, patients saw a significant reduction in protein levels in their urine—specifically, a drop of 47.6% in the urinary albumin-to-creatinine ratio and a 22.2% decrease in 24-hour proteinuria. Importantly, their kidney function remained stable during this time, which is notable since it usually declines in such patients. Who this helps: This research benefits patients with Fabry disease and chronic kidney disease.

Plain English
This study looked at a new way to monitor blood pressure using a "Smart Sock" that measures blood flow in the foot without needing a traditional cuff. Researchers tested this method on 60 people and found that it could estimate blood pressure with a small error margin of around 1.3 to 1.7 mmHg after proper calibration, which is much better than traditional methods. This is important because it offers a comfortable, continuous way to track blood pressure in everyday settings, helping manage health more effectively. Who this helps: Patients who need regular blood pressure monitoring.

Plain English
This study looked at how well a new scoring system called the modified RUST (mRUST) works to measure healing in fractures for patients with osteogenesis imperfecta (OI), a condition that makes bones fragile. Researchers evaluated x-rays from 30 OI patients and found that the mRUST score shows high reliability, with scores consistently similar among different observers. This means doctors can trust the mRUST to accurately assess bone healing in these patients, which is important for making informed treatment decisions. Who this helps: This helps patients with osteogenesis imperfecta and their doctors.

Plain English
This study looked at how age and sex affect acute kidney injury (AKI) in over 87,000 hospitalized adults. It found that 20.6% of patients developed AKI, with more females (21.4%) affected than males (19.8%). Older males had worse outcomes, while younger males were more likely to experience AKI than younger females, indicating that understanding both sex and age is important for better care during AKI. Who this helps: This helps doctors treat patients with AKI more effectively by understanding how sex and age interact.

Plain English
This study examined how children's muscle strength, neuromuscular control, and resilience are related by testing 164 fourth- and fifth-graders at two points during the school year. The researchers found that measurements of muscle strength, like jumping and push-ups, were connected; specifically, better push-up performance predicted better jumping ability, with strong correlations between these activities. However, neuromuscular control and resilience did not show significant connections to muscle strength. Who this helps: This information benefits teachers and parents looking to enhance physical activity programs for children.

Plain English
This study focused on a rare kidney disease called TRPC6-associated podocytopathy (TRPC6-AP) by analyzing data from 64 patients across 39 families. It found that many patients showed specific kidney damage patterns and that the disease often starts in the teens or early twenties, with an average onset age of 22 years, while most patients eventually face kidney failure at varying rates. Understanding the genetic and clinical features of this disease is crucial for developing targeted treatments and improving future clinical trials. Who this helps: This research benefits patients with TRPC6-AP and their doctors by informing treatment approaches and clinical trial designs.

Plain English
This study looked at how the kidneys and other organs in the body remove a protein called adiponectin from the blood. It found that the levels of adiponectin were significantly lower in samples taken from the liver and kidney compared to the arteries supplying blood to these organs, with decreases of about 32% and 20%. This is important because it suggests that a decrease in how well the kidneys process adiponectin might lead to higher levels of it in people with kidney disease, which could affect their overall health. Who this helps: This helps patients with kidney disease.

Plain English
This study explored a rare kidney-related condition called Monoclonal Gammopathy of Renal Significance (MGRS) by examining 34 patients. Researchers found that while both major types of MGRS (AL amyloidosis and other forms) had similar overall survival rates, the AL amyloidosis type led to a more aggressive disease course, with patients living an average of only 206 days after diagnosis compared to 728 days for the other type. The study highlights the importance of better diagnosing and treating these conditions to improve patient outcomes. Who this helps: This helps patients with MGRS and their doctors in choosing effective treatments.

Plain English
This study looked at acute kidney injury (AKI) in hospitalized patients across Italian hospitals from 2016 to 2019. Out of over 87,000 patients, about 20.6% developed AKI, which significantly increased their chances of dying (17.7% compared to 4.3% in patients without AKI) and led to longer hospital stays. The study highlights the need for early detection and personalized care for patients with AKI to improve their outcomes and reduce the risk of long-term kidney problems. Who this helps: This helps patients at risk of kidney injury and their healthcare providers.

Plain English
This study looked at the use of a blood purification method called hemoadsorption to treat severe complications in patients with blood cancers after they received CAR-T cell therapy. Out of 48 patients, 4 (about 8.3%) had severe side effects, and their condition improved after hemoadsorption was applied, leading to a significant decrease in harmful inflammatory markers for three of them. This is important because it shows that hemoadsorption can help manage dangerous side effects of CAR-T therapy and may improve recovery outcomes for some patients. Who this helps: Patients undergoing CAR-T therapy who experience severe side effects.

Plain English
This study looked at genetic changes in children with congenital kidney malformations to better understand their causes. Researchers found that about 14.1% of these cases had specific genetic variants that could explain their kidney issues, and 18% of those with these variants also had other developmental problems, like neurological or heart issues. Identifying these genetic links is important because it could help in diagnosing and understanding other related disorders. Who this helps: This benefits patients with kidney malformations and their families, as well as doctors trying to diagnose and treat these conditions.

Plain English
This study looked at how kidney function changes after a type of weight-loss surgery called biliopancreatic diversion (BPD) and how those changes relate to the risk of death in patients. Researchers followed 284 patients for about 16 years and found that while 16% of them died during that time, those who saw an improvement in kidney function within the first year after surgery had a lower risk of dying. However, a continued increase in kidney function beyond that first year was linked to a higher risk of death, indicating that doctors need to closely monitor these patients over time. Who this helps: This helps patients undergoing weight-loss surgery and their doctors.

Plain English
This study looked at how a cholesterol-lowering drug called PEP 2-8 can protect kidneys from damage during a specific type of kidney transplant process in rats. The results showed that PEP 2-8 reduced kidney injury and improved energy levels in the tissue, with a significant decrease in cell damage markers: after treatment, there was a 67% drop in lactate dehydrogenase (LDH) release and better cell health indicators. These findings are important because they suggest that PEP 2-8 might help improve kidney function after transplantation, leading to better outcomes for patients receiving transplanted kidneys. Who this helps: Patients receiving kidney transplants.

Plain English
This study looked at the levels of a protein called C3 in patients with lupus nephritis, a kidney condition related to lupus, to see if low C3 levels could predict long-term kidney problems. Researchers found that 91 out of 445 patients had low C3 levels and they were twice as likely to experience serious issues like chronic kidney disease or kidney failure compared to those with normal C3 levels. This matters because it helps identify patients who need closer monitoring and possibly earlier treatment to prevent severe kidney damage. Who this helps: This helps patients with lupus nephritis and their doctors.

Plain English
This research looked at how neutrophil extracellular traps (NETs), which are structures released by immune cells, can influence cancer cells and their ability to spread in the body. The findings suggest that NETs promote cancer growth and help cancer cells move to new areas, especially during severe infections or after surgery. This is important because understanding how NETs contribute to cancer can help develop new treatments to slow down or prevent cancer spread. Who this helps: Patients with cancer and their doctors.

Plain English
This study looked at whether a shorter recess program could help improve muscular strength, control over movements, and resilience in fourth and fifth graders. The researchers tested 164 students before and after participating in a modified version of the LiiNK Project, which shortened the daily recess from 60 minutes to 30 minutes. They found no significant improvements in strength or control, suggesting that 30 minutes might not be enough for these benefits. Who this helps: This research is important for educators and school administrators who make decisions about recess programs for elementary school children.

Plain English
This study looked at how a protein called DNAJB6 affects the behavior of harmful protein clumps linked to diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Researchers found that DNAJB6 helped keep these protein clumps in a safe, gel-like state instead of letting them turn toxic, which could be crucial in slowing down cell damage in these conditions. In experiments with mice that model FUS-ALS, increasing DNAJB6 levels helped prevent the loss of motor neurons and reduce inflammation. Who this helps: Patients with ALS and FTD.

Plain English
This study looked at how sleep disruption in adolescent mice (specifically male and female CD-1 mice) affects a protective barrier in the brain called the blood-brain barrier (BBB). Researchers found that after a week of disrupted sleep, female mice showed significantly more permeability in the BBB in specific brain areas compared to males and those with normal sleep. These findings show that adolescent sleep problems can lead to increased vulnerability in brain function, especially in females, which is important for understanding how sleep issues might impact mental health during these crucial developmental years. Who this helps: This benefits researchers, doctors, and mental health professionals dealing with adolescent health issues.

Plain English
This study looked at how often patients on hemodialysis are at risk of suicide. It found that about 20.6% of these patients are at risk, with numbers varying significantly from as low as 4.0% to as high as 57.3% depending on the assessment methods used. The risk is particularly higher in lower-income countries, where 33.5% of patients are at risk compared to 15.3% in higher-income countries. This information is important because it highlights a serious mental health issue among dialysis patients that is much greater than what is seen in the general population. Who this helps: This helps patients, doctors, and healthcare providers understand the mental health challenges faced by those undergoing dialysis.

Plain English
This study looked at a protein called HAPLN2, which builds up in the brains of aging mice and contributes to inflammation. The researchers found that this protein accumulates because aging affects the brain's ability to clear it out, which in turn activates immune cells in the brain called microglia, leading to increased inflammation. These findings are important because they help us understand how aging can affect brain health and may contribute to neurodegenerative diseases in the future. Who this helps: This helps researchers and doctors working on brain aging and neurodegenerative diseases.

Plain English
This study examined a specific marker in kidney cells, called SA-β-Gal, to see if it could predict how quickly patients with chronic kidney disease (CKD) would lose kidney function. Researchers found that SA-β-Gal levels in kidney tissues were four times higher in CKD patients (about 26%) compared to healthy controls (about 7%). They discovered that if more than 30% of kidney tubules showed high SA-β-Gal, it linked to faster deterioration of kidney function, highlighting its potential as a warning sign for doctors. Who this helps: This helps patients with chronic kidney disease and their doctors by providing a way to predict disease progression.

Plain English
This study looked for microplastics in human urine and kidney tissue using a technique called microRaman spectroscopy. Researchers found 26 microplastic particles from healthy kidney and urine samples, with particle sizes ranging from 1 to 29 micrometers in kidneys and 3 to 13 micrometers in urine. The presence of these particles, particularly polyethylene and polystyrene, indicates that microplastics can accumulate in human kidneys, which raises concerns about their impact on health. Who this helps: This information helps doctors and researchers understand the potential health risks of microplastics for patients.

Plain English
This study focused on the role of autoantibodies in lupus nephritis (a kidney problem related to lupus) and found that specific types, like anti-dsDNA IgG2, don't help distinguish between kidney and non-kidney cases of lupus. Instead, other antibodies, such as anti-ENO1 and anti-H2 IgG2, were higher in people with kidney issues at diagnosis and dropped after treatment. These findings are significant because they suggest that measuring these antibodies can better guide treatment decisions for lupus nephritis. Who this helps: Patients with lupus nephritis and their doctors.

Plain English
This study explored how Renewable Energy Communities can be set up within the European Union to help achieve carbon neutrality by 2050. Researchers outlined a step-by-step plan that includes assessing energy needs, bringing together members to form a legal group, building the energy facilities, and managing the project. This approach can lead to better use of renewable energy, benefiting the environment and local economies. Who this helps: This helps communities and local governments aiming to adopt renewable energy solutions.

Plain English
This study looked at a powerful explosion known as a giant flare from a type of star called a magnetar, specifically in the nearby galaxy M82. Researchers found that a burst of gamma rays, called GRB 231115A, matched the characteristics of magnetar flares with a brightness reaching around 10^53 ergs. The discovery of this flare is significant because it adds to the understanding of such rare events and helps scientists explore the workings of neutron stars beyond our galaxy. Who this helps: This benefits astronomers studying the universe and the behavior of neutron stars.

Plain English
This study looked at how SGLT2 inhibitors, a type of medication used mainly for diabetes, can help slow down the aging process in the kidneys and combat chronic kidney disease (CKD). Researchers found that SGLT2 inhibitors can reduce inflammation and cellular damage associated with kidney aging, which is important because these factors can worsen CKD. The findings suggest that using these medications could be a key strategy in managing kidney health as people age. Who this helps: This helps patients with chronic kidney disease and those at risk of kidney problems.

Plain English
This study looked at how physical exercise affects kidney patients and the role of myokines, which are substances released by muscles during activity. The researchers found that exercise can improve muscle mass, physical function, and overall health in chronic kidney disease (CKD) patients by influencing various bodily processes. Understanding how exercise and myokines interact is vital because it could help improve the quality of life and outcomes for kidney patients. Who this helps: This helps kidney patients and doctors treating them.

Plain English
This study investigated how treatments with antimicrobial agents and a bacterial component (lipopolysaccharide) during puberty affect brain functions and behavior in male and female mice. The researchers found that female mice exposed to both treatments had weaker muscle control, while male mice showed more anxiety when given lipopolysaccharide alone. These changes are linked to differences in specific brain proteins that are important for brain health, indicating that early exposure to these substances may lead to ongoing problems with brain function and behavior. Who this helps: This research benefits patients, particularly young people at risk of neurodegenerative issues due to infections or antibiotic use.

Plain English
This study looked at how certain treatments during puberty, specifically antimicrobial agents and a stress-inducing substance called lipopolysaccharide, affect the protective barrier in the brain of young male and female mice. The researchers found that these treatments increased sickness behaviors and altered body temperature and heart rates differently based on the sex of the mice. Additionally, the treatments caused a temporary increase in the permeability of the blood-brain barrier, which could have lasting effects on brain health. Who this helps: This research benefits patients at risk for neurodegenerative disorders, particularly those who may experience stress during puberty.

Plain English
This study looked at how well hospitals recognize acute kidney injury (AKI) in patients and found that many cases go undetected. Out of over 56,000 patients, about 24.5% had AKI, but 68% of those cases were not identified or documented properly, which can lead to worse outcomes. Recognizing AKI is crucial since even undetected cases increase the risk of death, highlighting the need for better diagnosis in hospitals. Who this helps: This helps patients by improving their chances of receiving timely and appropriate care for kidney issues.

Plain English
This study looked at patients with systemic lupus erythematosus (SLE) in Italy, comparing Caucasian and Hispanic individuals to see how their disease characteristics differ. Among the 126 patients studied, Caucasian patients had a longer disease duration (20.4 years) and a slightly higher damage score (2.11) compared to Hispanic patients (14.2 years and 1.88, respectively). However, these differences mostly disappeared when accounting for how long patients had the disease, suggesting that access to healthcare is a bigger factor in disease outcomes than ethnicity. Who this helps: This research benefits patients by highlighting the importance of access to healthcare in managing lupus, regardless of ethnic background.

Plain English
This study looked at how microplastics and Bisphenol A (BPA), a chemical found in some plastics, affect human kidney cells. The researchers found that when kidney cells were exposed to both substances together, their survival rates dropped significantly, by about 50%, compared to when cells were exposed to each substance alone. This is important because it highlights how common environmental pollutants like microplastics and BPA might work together to harm our kidneys, which can lead to serious health issues. Who this helps: This research helps patients with kidney problems and advocates for reducing exposure to harmful chemicals.

Plain English
This study looked at patients with blood cancers who were treated with CAR-T therapy and focused on the risk and impact of acute kidney injury (AKI). Of the 48 patients studied, 14 (29%) developed AKI about six days after their treatment, which led to more complications and worse survival rates. Specifically, severe AKI increased the risk of early death and issues with surviving without disease by making outcomes significantly worse. Who this helps: This research benefits patients undergoing CAR-T therapy, guiding doctors in monitoring and managing their kidney health.

Plain English
This research paper examines how physical activity affects people with Fabry disease, a genetic condition that leads to problems with a specific enzyme, impacting various body parts, especially muscles and the heart. It finds that many patients experience exercise intolerance, which can degrade their quality of life, but exercise training alongside existing treatments can help alleviate some of these issues. For patients with Fabry disease, integrating exercise into their care may significantly improve their well-being and daily functioning. Who this helps: Patients with Fabry disease and their healthcare providers.

Plain English
This research paper examines how tiny plastic particles, known as microplastics, can accumulate in human organs, especially the kidneys. It highlights that microplastics are found in many areas of the human body, including organs like the liver and lungs, and discusses concerns that they may cause damage, as seen in animal studies where they led to kidney issues. The paper calls for more research to understand the relationship between exposure to microplastics and kidney disease. Who this helps: This information is valuable for patients, particularly those with kidney issues, as well as healthcare providers looking to understand potential environmental factors affecting health.

Plain English
This research looked at kidney damage in cancer patients who were treated with immune checkpoint inhibitors (ICIs), focusing on a specific condition called acute tubulointerstitial nephritis (ATIN). They found that out of 85 patients, 65.5% developed severe kidney injury after an average of four treatment cycles, especially among those receiving combined ICI therapies, with many needing steroid treatment and some experiencing a recurrence of kidney issues when therapy resumed. This matters because understanding these risks can help doctors monitor and manage kidney health in patients undergoing cancer treatment, potentially improving patient outcomes. Who this helps: This helps patients undergoing cancer treatment, particularly those using immune checkpoint inhibitors.

Plain English
This study looked at a protein called CD46 in the brains of young mice and how its levels change after certain treatments. Researchers found that this protein is present in specific brain areas, but when mice received a treatment that mimics infection (using LPS), the levels of CD46 decreased, particularly in male mice. This matters because understanding how CD46 works in the brain could help us learn more about immune responses and how they differ between males and females. Who this helps: This research benefits scientists and researchers studying immune responses and brain function.

Plain English
This study looked at how diabetes affects kidney health, highlighting that diabetes is a leading cause of chronic kidney disease, with symptoms ranging from no symptoms at all to serious kidney failure. It found that diabetes can cause various damaging changes in the kidneys, such as thickening of kidney structures and loss of vital cells, but it also recognized that kidney diseases unrelated to diabetes can occur in these patients. Understanding this relationship is important for doctors to properly diagnose and treat patients, as these overlapping kidney issues can affect treatment choices. Who this helps: This helps patients with diabetes and kidney problems, as well as their doctors.

Plain English
This research paper focused on Fabry disease, a genetic condition that affects kidney function and can lead to serious health issues. The study found that diagnosing Fabry nephropathy can be difficult because its symptoms, like protein in the urine and general kidney damage, can look similar to other kidney problems. It's important to correctly identify Fabry disease early because there are treatments available that can help prevent further damage to the organs. Who this helps: This helps patients with kidney disease and their doctors identify and treat Fabry disease more effectively.

Plain English
This study looked at how NCAA Division I athletes from team sports and individual sports use relaxation techniques and mental imagery to manage stress and improve their performance. The results showed that team sport athletes preferred techniques like muscle relaxation and stretching, while individual sport athletes were more likely to use performance imagery to maintain focus. This is important because understanding these differences can help tailor psychological training for athletes, enhancing their performance and well-being. Who this helps: This benefits athletes, coaches, and sports psychologists.

Plain English
This research examined a group of proteins called carboxypeptidase inhibitors found in plants like potatoes and tomatoes. The study identified key sequences of these proteins, showing that they have unique properties that help protect plants from pests and diseases, with the potential for broader antimicrobial action. This matters because using these proteins could lead to better ways to protect crops from harmful pathogens, ultimately improving agricultural sustainability. Who this helps: Farmers and agricultural scientists.